FDA ANDA · ANDA210762
FENTANYL CITRATE
Sponsor: FRESENIUS KABI USA
What this page does not claim
A drug page is a reference view of public FDA data (Drugs@FDA), reproduced as published. SPEQ is not affiliated with the FDA, adds no interpretation to the record, and nothing here is medical, legal, or regulatory advice.
APPLICATION
ANDA210762
TYPE
ANDA
ORIGINAL APPROVAL
2019-05-03
LATEST ACTION
2026-10-01
ROUTE
INTRAMUSCULAR, INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
FENTANYL CITRATE PRESERVATIVE FREEPrescription
FENTANYL CITRATE EQ 0.05MG BASE/ML · INJECTABLE · INJECTION
Approval history
2026-10-01Labeling · Supplement 10 · standardAP
2026-10-01Labeling · Supplement 11 · standardAP
2025-04-24Labeling · Supplement 8 · standardAP
2025-04-24Labeling · Supplement 6 · standardAP
2025-04-24Labeling · Supplement 7 · standardAP
2020-05-07Labeling · Supplement 1 · standardAP
Source: FDA Drugs@FDA. Browse every approval SPEQ tracks →